跳至主要内容
临床试验/EUCTR2018-001312-30-GB
EUCTR2018-001312-30-GB进行中(未招募)1 期

SPRING - Seizure PRophylaxis IN Glioma - SPRING - Seizure PRophylaxis IN Glioma

Common Services Agency0 个研究点目标入组 804 人开始时间: 2018年10月16日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
804

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1)Patients with suspected cerebral glioma on MRI
  • ?2)Capable of giving informed consent
  • ?3)Patients must be = 16 years old
  • ?4)Patients must have a Karnofsky performance status =70
  • ?5)Patients must be able to safely swallow pills
  • 6)Planned surgery for presumed glioma (biopsy or resection)
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 8
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 474
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 322

排除标准

  • 1)Pregnant
  • 2)History of any type of seizure for at least 10 years prior to randomisation ?3)Known Severe Chronic Kidney Disease (CKD4 - eGFR < 30ml/min)
  • 4)Concomitant methotrexate
  • 5)Concomitant AED (including use for other reasons (e.g. pain))
  • 6)Concomitant benzodiazepines
  • 7)Hypersensitivity to levetiracetam

研究者

发起方
Common Services Agency

相似试验